HypErsensitiVity PneumonITis: DiseAse Progression Characterization
Condition(s):Hypersensitivity PneumonitisLast Updated:June 29, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Hypersensitivity PneumonitisLast Updated:June 29, 2023Recruiting
Condition(s):Hypersensitivity PneumonitisLast Updated:December 22, 2023Recruiting
Condition(s):Hypersensitivity PneumonitisLast Updated:September 28, 2023Not yet recruiting
Condition(s):Hypersensitivity PneumonitisLast Updated:November 30, 2022Recruiting
Condition(s):Hypersensitivity PneumonitisLast Updated:March 20, 2024Recruiting
Condition(s):Sensitisation; Mold or Dust Allergy; Respiratory DiseaseLast Updated:January 30, 2023Not yet recruiting
Condition(s):Interstitial Lung Disease; Sarcoidosis; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Hypersensitivity PneumonitisLast Updated:November 28, 2023Recruiting
Condition(s):Interstitial Lung Disease; Idiopathic Pulmonary Fibrosis; Hypersensitivity Pneumonitis; Scleroderma; Nonspecific Interstitial PneumoniaLast Updated:December 14, 2023Not yet recruiting
Condition(s):Interstitial Lung Disease; Idiopathic Interstitial Pneumonias; Drug-Induced Pneumonitis; Hypersensitivity Pneumonitis; Radiation Pneumonitis; Pneumoconiosis; Pulmonary FibrosisLast Updated:April 13, 2023Recruiting
Condition(s):Interstitial Lung DiseaseLast Updated:July 19, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.